John W. Bristol & Co’s Bristol-Myers Squibb BMY Stock Holding History

John W. Bristol & Co’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-11,070	Closed	-$767K	–	72
2023 Q1	$767K	Hold	11,070	–	–	0.02%	64
2022 Q4	$796K	Hold	11,070	–	–	0.02%	61
2022 Q3	$787K	Hold	11,070	–	–	0.02%	61
2022 Q2	$852K	Hold	11,070	–	–	0.02%	55
2022 Q1	$808K	Hold	11,070	–	–	0.02%	61
2021 Q4	$690K	Hold	11,070	–	–	0.01%	67
2021 Q3	$655K	Hold	11,070	–	–	0.01%	67
2021 Q2	$740K	Hold	11,070	–	–	0.01%	66
2021 Q1	$699K	Hold	11,070	–	–	0.01%	63
2020 Q4	$687K	Hold	11,070	–	–	0.01%	57
2020 Q3	$667K	Buy	+11,070	New	+$666K	0.02%	54

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

John W. Bristol & Co's BMY Position: Q2 2023 in Review

John W. Bristol & Co sold out of Bristol-Myers Squibb (BMY) in Q2 2023, closing a stake of 11,070 shares — an estimated $767K sold.

John W. Bristol & Co first reported a position in BMY in Q3 2020 and held it in 11 quarters. The position peaked at $852K in Q2 2022. 2,480 funds tracked by Wall St. Rank hold BMY as of Q2 2023.

John W. Bristol & Co reported no remaining Bristol-Myers Squibb position as of Q2 2023 after selling out during the quarter.
John W. Bristol & Co sold 11,070 Bristol-Myers Squibb shares in Q2 2023, an estimated $767K.
John W. Bristol & Co first reported a position in Bristol-Myers Squibb in Q3 2020 and held it in 11 quarters.
John W. Bristol & Co's Bristol-Myers Squibb position peaked at $852K in Q2 2022.
2,480 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2023.

Based on John W. Bristol & Co's 13F filing for Q2 2023, filed 28 Jul 2023.